Previously Recorded
Digital Health Investment Trends & 2022 Outlook
Event summary
Join us for a Cooley Healthtech Talks webinar with leading venture capitalists for an inside look at digital health investments trends and predictions for 2022. Our panelists will share their investment outlook and relay advice to entrepreneurs who are fundraising. Discussion topics will include deal terms in the current environment, best practices for fundraising and criteria to lead a deal, as well as which sectors are poised for success. Cooley Healthtech Talks is a forum for leading executives, investors, entrepreneurs and thought leaders in the healthtech industry.
Speakers
- Josh Seidenfeld – Partner, Cooley
- Ambar Bhattacharyya – Managing Director, Maverick Ventures
- Billy Deitch – Partner, Oak HC/FT
- Dan Gebremedhin, MD – Partner, Flare Capital
This webinar is part of our 2022 Life Sciences & Healthcare Innovation Program, Cooley’s 15th annual event in conjunction with the J.P. Morgan Healthcare Conference.
For more information, please email Ilana Brand.
Related contacts
This content is provided for general informational purposes only, and your access or use of the content does not create an attorney-client relationship between you or your organization and Cooley LLP, Cooley (UK) LLP, or any other affiliated practice or entity (collectively referred to as “Cooley”). By accessing this content, you agree that the information provided does not constitute legal or other professional advice. This content is not a substitute for obtaining legal advice from a qualified attorney licensed in your jurisdiction and you should not act or refrain from acting based on this content. This content may be changed without notice. It is not guaranteed to be complete, correct or up to date, and it may not reflect the most current legal developments. Prior results do not guarantee a similar outcome. Do not send any confidential information to Cooley, as we do not have any duty to keep any information you provide to us confidential. This content may be considered Attorney Advertising and is subject to our legal notices.